Form 4: Haemonetics Corp Executive Michelle Basil Reports Stock Disposals for Tax Obligations

Michelle Basil, EVP and General Counsel of Haemonetics Corp, reported disposing of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On May 15, 2025, Michelle Basil, EVP and General Counsel of Haemonetics Corp, disposed of 622 shares of common stock at a price of $69.38 to cover tax obligations.
• Following this transaction, Ms. Basil directly owns 30,635 shares of Haemonetics Corp.
• On May 16, 2025, Ms. Basil disposed of 2,157 shares of common stock at a price of $70.31 to cover tax obligations.
• Following this transaction, Ms. Basil directly owns 28,478 shares of Haemonetics Corp, including unvested RSUs.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing relates to routine stock disposals for tax purposes and doesn't indicate any significant positive or negative developments for the company.

Industry Context

Executive stock transactions are a common occurrence and are often related to compensation and tax planning. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.

Key Dates

Keywords

Form 4, Beneficial Ownership, Executive Compensation, Stock Disposal, Haemonetics Corp, Michelle Basil, HAE